Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parenthetical)

v3.25.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Discount, current $ 237  
Preferred stock, authorized (in shares) 1,000,000 1,000,000
Preferred stock, par or stated value (in dollars per share) $ 0.0005 $ 0.0005
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, authorized (in shares) 50,000,000 50,000,000
Common stock, par or stated value (in dollars per share) $ 0.0005 $ 0.0005
Common stock, outstanding (in shares) 29,874,029 18,045,029
Treasury stock (in shares) 12,940,967 [1] 18,940,967
Issuance of treasury shares as collateral for a loan (in shares) 6,000,000  
JXVII Note    
Discount, non-current $ 127 $ 266
ERC Claim    
Discount, non-current $ 423  
[1] This is net of 6,000,000 collateral shares, see Note 6.